| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |